Journal of Bioequivalence & Bioavailability

Wei Wang

Wei Wang
Department of Pharmaceutical Science, School of Pharmacy, Texas Tech University Health Sciences Center
USA

Biography

After graduation from Medical School in 1999, I developed an interest in basic biomedical research and went ahead and obtained a Master of Science degree in molecular biology in 2003. I did my first post-doctoral training in cancer biology and clinical oncology between 2003 and 2004 in Peking Union Medical College and Chinese Academy of Medical Sciences, one of the best medical schools in China, focusing on pharmacogenomics of cancer therapy. Between 2004 and 2007, I was a post-doctoral researcher in the Medical School of University of Alabama at Birmingham (UAB), conducting research in oncogene expression and regulation. Between 2008 and 2010, I was the supervisor and lab manger of Cancer Pharmacology Laboratory (NCI contract lab) at UAB. I joined the faculty at TTUHSC in August 2010. With over 10 years of post-doctoral experience in the field of cancer research, particularly in the area of clinical cancer pharmacology and experimental therapeutics, my research has been continuously focused on molecular targeting for cancer therapy and prevention. My particular interests include development of experimental therapeutic agents and evaluation of their mechanism(s) of action, toxicity, and pharmacokinetics.

Research Interest

Cancer research, biochemistry, molecular biology, animal physiology and pharmacology, cancer chemotherapy, antisense therapy and gene silencing, regulation of oncogene and tumor suppressor gene, disease model, pharmaceutical sciences, preclinical and clinical drug development, translational research/clinical trials.